Arthralgia as an adverse event to infliximab: a reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept

Arthralgia as an adverse event to infliximab: a reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept

Saved in:
Bibliographic Details
Published in:Journal of the European Academy of Dermatology and Venereology Vol. 23; no. 8; pp. 968 - 969
Main Authors: Moustou, AE, Stratigos, AJ, Vergou, T, Gregoriou, S, Georgala, S, Danopoulou, I
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01-08-2009
Subjects:
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal - therapeutic use
Antirheumatic Agents - adverse effects
Antirheumatic Agents - therapeutic use
Arthralgia - chemically induced
Arthralgia - diagnosis
Arthritis, Psoriatic - chemically induced
Arthritis, Psoriatic - diagnosis
Arthritis, Reactive - chemically induced
Arthritis, Reactive - diagnosis
Diagnosis, Differential
Etanercept
Humans
Immunoglobulin G - adverse effects
Immunoglobulin G - therapeutic use
Infliximab
Male
Middle Aged
Psoriasis - drug therapy
Receptors, Tumor Necrosis Factor - therapeutic use
Severity of Illness Index
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:istex:156BC8818417706888FA9772040EF2F6D367753E
ark:/67375/WNG-62KMM151-K
ArticleID:JDV3075
DOI: 10.1111/j.1468‐3083.2008.03075.x
ISSN:0926-9959
1468-3083
DOI:10.1111/j.1468-3083.2008.03075.x